BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11445736)

  • 21. Coagulation in sepsis: all bugs bite equally.
    Levi M; van der Poll T
    Crit Care; 2004 Apr; 8(2):99-100. PubMed ID: 15025767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The loss of homeostasis in hemostasis: new approaches in treating and understanding acute disseminated intravascular coagulation in critically ill patients.
    Hook KM; Abrams CS
    Clin Transl Sci; 2012 Feb; 5(1):85-92. PubMed ID: 22376264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombomodulin as a Physiological Modulator of Intravascular Injury.
    Watanabe-Kusunoki K; Nakazawa D; Ishizu A; Atsumi T
    Front Immunol; 2020; 11():575890. PubMed ID: 33042158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activated protein C, a protein at the crossroads between coagulation and inflammation].
    Borgel D; Vieillard-Baron A
    Med Sci (Paris); 2011 May; 27(5):501-7. PubMed ID: 21609671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum thrombomodulin level relates to the clinical course of disseminated intravascular coagulation, multiorgan dysfunction syndrome, and mortality in patients with sepsis.
    Lin SM; Wang YM; Lin HC; Lee KY; Huang CD; Liu CY; Wang CH; Kuo HP
    Crit Care Med; 2008 Mar; 36(3):683-9. PubMed ID: 18431261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sepsis, coagulation and anticoagulants.
    Machado FR; Cesar MS
    Endocr Metab Immune Disord Drug Targets; 2010 Sep; 10(3):204-13. PubMed ID: 20509839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infection and inflammation and the coagulation system.
    Levi M; Keller TT; van Gorp E; ten Cate H
    Cardiovasc Res; 2003 Oct; 60(1):26-39. PubMed ID: 14522404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
    Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y
    Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant soluble thrombomodulin: coagulation takes another chance to reduce sepsis mortality.
    Levi M
    J Thromb Haemost; 2015 Apr; 13(4):505-7. PubMed ID: 25650725
    [No Abstract]   [Full Text] [Related]  

  • 30. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
    Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
    J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managing sepsis-associated coagulopathy remains an enigma.
    Thachil J
    J Thromb Haemost; 2019 Oct; 17(10):1586-1589. PubMed ID: 31376202
    [No Abstract]   [Full Text] [Related]  

  • 32. Severe sepsis, coagulation, and fibrinolysis: dead end or one way?
    Fourrier F
    Crit Care Med; 2012 Sep; 40(9):2704-8. PubMed ID: 22732284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-centre, open-label, randomised controlled trial.
    Hagiwara A; Tanaka N; Uemura T; Matsuda W; Kimura A
    BMJ Open; 2016 Dec; 6(12):e012850. PubMed ID: 28039291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis of disseminated intravascular coagulation in sepsis.
    Levi M; ten Cate H; van der Poll T; van Deventer SJ
    JAMA; 1993 Aug; 270(8):975-9. PubMed ID: 8345649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis.
    Esmon CT
    Baillieres Clin Haematol; 1994 Sep; 7(3):453-68. PubMed ID: 7841595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coagulopathy of Acute Sepsis.
    Semeraro N; Ammollo CT; Semeraro F; Colucci M
    Semin Thromb Hemost; 2015 Sep; 41(6):650-8. PubMed ID: 26305237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sepsis and disseminated intravascular coagulation.
    Levi M; de Jonge E; van der Poll T
    J Thromb Thrombolysis; 2003; 16(1-2):43-7. PubMed ID: 14760211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anticoagulant factor concentrates in disseminated intravascular coagulation: rationale for use and clinical experience.
    de Jonge E; van der Poll T; Kesecioglu J; Levi M
    Semin Thromb Hemost; 2001 Dec; 27(6):667-74. PubMed ID: 11740690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
    Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
    Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
    Wu KK; Matijevic-Aleksic N
    Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.